Cencora (COR) Competitors

Elevance Health (NYSE:ELV) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.

Which has higher valuation and earnings, ELV or COR?

Elevance Health has higher revenue and earnings than Cencora. Elevance Health is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$177.01B	0.45	$5.98B	$23.50	14.94
Cencora	$638.56M	91.86	$1.51B	$9.72	31.13

Does the media refer more to ELV or COR?

In the previous week, Elevance Health had 11 more articles in the media than Cencora. MarketBeat recorded 33 mentions for Elevance Health and 22 mentions for Cencora. Cencora's average media sentiment score of 1.52 beat Elevance Health's score of 1.22 indicating that Cencora is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	24 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Positive
Cencora	19 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Do insiders & institutionals believe in ELV or COR?

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 0.3% of Elevance Health shares are held by company insiders. Comparatively, 10.8% of Cencora shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Which has more volatility & risk, ELV or COR?

Elevance Health has a beta of 0.59, meaning that its stock price is 41% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.63, meaning that its stock price is 37% less volatile than the S&P 500.

Is ELV or COR a better dividend stock?

Elevance Health pays an annual dividend of $6.84 per share and has a dividend yield of 1.9%. Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.7%. Elevance Health pays out 29.1% of its earnings in the form of a dividend. Cencora pays out 22.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 14 consecutive years and Cencora has raised its dividend for 15 consecutive years.

Do analysts prefer ELV or COR?

Elevance Health presently has a consensus price target of $411.06, suggesting a potential upside of 17.07%. Cencora has a consensus price target of $311.25, suggesting a potential upside of 2.88%. Given Elevance Health's higher possible upside, equities analysts plainly believe Elevance Health is more favorable than Cencora.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	1 Sell rating(s)	6 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.58
Cencora	0 Sell rating(s)	3 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.77

Is ELV or COR more profitable?

Elevance Health has a net margin of 2.83% compared to Cencora's net margin of 0.60%. Cencora's return on equity of 267.36% beat Elevance Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.83%	17.59%	6.36%
Cencora	0.60%	267.36%	4.31%

Summary

Cencora beats Elevance Health on 10 of the 19 factors compared between the two stocks.